SEMINAR | Patient Voices and Pharma Innovation: Enhancing Patient Centricity and Public Involvement in Pharma

Patient Centricity—an approach aimed at developing pharmaceuticals and providing medical services that reflect the needs and perspectives of patients—and Patient and Public Involvement (PPI), which refers to the active involvement of patients and the public in medical research and policymaking, have recently become buzzwords. In Europe and the US, several pharmaceutical companies have integrated these approaches, demonstrating improvements in the quality of drug development and patient care. In Japan, these initiatives are gradually spreading, but it is still in the early stages of implementation and faces unique challenges. 

Join Us

Join us for this seminar, which will introduce trends and practical approaches to Patient Centricity and PPI in Japan, from drug development to post-launch patient engagement, and explore patient-centered activities. We will discuss how patients, healthcare professionals, policymakers, and various departments within pharmaceutical companies—from clinical development to sales and marketing—can collaborate to meet the needs and expectations of patients. 

Featured Speakers

Mr. Ryoji Noritake 

Representative Director and CEO, Health and Global Policy Institute 

Ms. Mieko Kawakubo 

Japan Country Manager, Head of Japan Business Development Operations, HanAll Biopharma

Mr. Shinsuke Amano

Board Chairman of Japan Federation of Cancer Patient Groups 

Mariko Matsubara

Clinical Registered Nurse, Site & Patient, Corporate Development Project Manager, Syneos Health 

Shigeto Miyamoto

Vice President, Digital Solutions, Asia-Pacific, Syneos Health